EP4722358A1 — Glycerol dehydratase variant and use thereof
Assigned to Ajou University Industry Academic Cooperation Foundation · Expires 2026-04-08 · 0y expired
What this patent protects
The present invention relates to a glycerol dehydratase variant and, more specifically, to a fusion glycerol dehydratase variant alleviating the inactivation of coenzyme B12 by oxygen or improving activity for glycerol, which is a substrate, and thus exhibits excellent activity e…
USPTO Abstract
The present invention relates to a glycerol dehydratase variant and, more specifically, to a fusion glycerol dehydratase variant alleviating the inactivation of coenzyme B12 by oxygen or improving activity for glycerol, which is a substrate, and thus exhibits excellent activity even under conditions of low coenzyme B12 concentration.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.